medroxyprogesterone has been researched along with Complications, Hematologic Pregnancy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BURSTEIN, R; WASSERMAN, HC | 1 |
| Altinoz, MA; Carin, MN; Gedikoglu, G; Ozdilli, K | 1 |
| Choudry, MA; Laber, DA; Moffett, BK | 1 |
1 review(s) available for medroxyprogesterone and Complications, Hematologic Pregnancy
| Article | Year |
|---|---|
Pure red-cell aplasia secondary to pregnancy, characterization of a syndrome.
Topics: Adrenal Cortex Hormones; Adult; Blood Transfusion; Female; Gestational Age; Humans; Infant, Newborn; Medroxyprogesterone; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Red-Cell Aplasia, Pure; Syndrome; Treatment Outcome | 2007 |
2 other study(ies) available for medroxyprogesterone and Complications, Hematologic Pregnancy
| Article | Year |
|---|---|
THE EFFECT OF PROVERA ON THE FETUS.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Drug Therapy; Female; Fetus; Humans; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Pregnancy Tests; Toxicology; Uterine Hemorrhage; Virilism | 1964 |
Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale.
Topics: Aspirin; Blood Transfusion, Intrauterine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobinopathies; Humans; Medroxyprogesterone; Models, Biological; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Third; Valproic Acid | 2007 |